あなたのバッジ 52週レンジ $2–$4 15% of range アナリスト評価 SELL 16 analysts 目標株価 $3 +16% upside P/E 1.5 ROE -16.7% 純利益率 2.1%

CYH 株価スナップショット 価格、時価総額、P/E、EPS、ROE、負債/資本、52週レンジ

03
株価 $2.72
時価総額 (MRQ) $384M
P/E (TTM) 1.5
EPS (TTM) $1.86
収益 (TTM) $11.98B
ROE (TTM) -16.7%
負債/自己資本 (MRQ) -6.9
52週レンジ $2–$4

CYH 株価チャート 技術指標付きの日次 OHLCV — パン、ズーム、ビューのカスタマイズ

04
範囲
バー

バーの粒度は選択した期間に合わせて調整されます。バーの始値/高値/安値/終値を確認するにはチャートにカーソルを合わせてください。

株式分割 1
権利落ち日 分割 タイプ
2016年4月22日 121-for-100 順

Community Health Systems, Inc. Common Stock について Wikipediaからの企業概要

05 · wikidata

Community Health Systems, Inc. (CHS) is a Fortune 500 company based in Franklin, Tennessee. It was the largest provider of general hospital healthcare services in the United States in terms of number of acute care facilities. In 2014, CHS had around 200 hospitals, but the number had declined to around 85 in 2021.

In August 2015, the company announced plans to spin off 38 hospitals and its management and consulting subsidiary, Quorum Health Resources, into a new publicly traded company called Quorum Health Corporation. The company completed the spinoff of Quorum Health Corporation on April 29, 2016. Quorum owns or leases hospitals across 16 states, primarily in cities or counties with populations of 50,000 or less. In April 2020 Quorum declared bankruptcy and is no longer trading on the NYSE.

On October 3, 2016, CHS was removed from the S&P Midcap 400 and added to the S&P Smallcap 600. Under CEO Wayne T. Smith, the company's stock has lost over 76% of its value since the year 2000.

Chinese billionaire Tianqiao Chen had a 22.2 percent stake in Community Health Systems in 2017.

History

Founding and early years (1985–2014)

E. Thomas Chaney, former executive of Hospital Affiliates, Inc. and David Steffy and Richard Ragsdale, former executives at Hospital Corporation of America spinoff Republic Health Corporation, formed Community Health Systems in 1985.

The company made its initial public offering in 1991. In 1996, the company was purchased by private equity firm Forstmann Little & Company. Community Health Systems went public again in 2000. In August 2003, the company acquired Southside Regional Medical Center. On October 10, 2015, the 372-bed Grandview Medical Center began operating in Birmingham, Alabama, replacing Trinity Medical Center.

In 2000, Community Health Systems paid $31 million to the United States Department of Justice to settle a review of its billing practices.

In 2007, Community Health Systems purchased Plano, Texas-based Triad Hospitals for $6.8 billion, adding nearly 50 hospitals, hospital management and consulting business Quorum Health Resources, and nearly doubling the size of the company. Among the facilities included in the deal was McKenzie-Willamette Hospital in Springfield, Oregon; Trinity Medical Center in Birmingham, Alabama; and the seven hospitals of Lutheran Health Network in the Ft. Wayne, Indiana region.

In 2010, McKenzie-Willamette's healthcare workers' union, SEIU, Local 49, claimed that workload increases, slashed benefits, and staff reductions had lowered the quality of both patient care and quality of life for employees. The union, in its "Profits Before Community" campaign against the hospital, continues to highlight that profits have tripled while charitable care and employee benefits have steadily decreased since the hospital moved from a non-profit to a for-profit enterprise under CHS.

In 2011, it was accused by Tenet Healthcare of overbilling Medicare in its aggressive admissions policy compared to its peers. It was subpoenaed by Medicare on its aggressive billing to the Medicare systems.

In 2013, Community Health Systems entered into an agreement with Health Management Associates to purchase HMA for about $3.6 billion in cash and stock. The merger was completed in January 2014 and made Community Health Systems the largest for-profit hospital operator at the time, with 206 hospitals in 29 states. The acquisition of HMA brought with it liability for lawsuits and criminal charges of fraudulent claims against Medicare and other federal programs. CHS settled these claims for $262 million in October, 2018.

On August 4, 2014, Community Health Systems paid $95.14 million to the United States Department of Justice to resolve multiple lawsuits "alleging that the company knowingly billed government health care programs for inpatient services that should have been billed as outpatient or observation services". As part of the agreement, Community Health Systems was required to enter into a corporate integrity agreement that required the company to participate in compliance efforts.

It was reported on August 18, 2014, that hackers broke into Community Health System's records system and stole data on 4.5 million patients. These data included names, Social Security numbers, physical addresses, birthdays and telephone numbers. CHS provided all patients whose records were impacted with free identity theft protection.

Recent developments (2015–present)

On February 2, 2015, Community Health Systems was required to pay $75 million to settle allegations "that they made illegal donations to county governments to reap more federal dollars under a now-discontinued matching program". The allegations were brought about by a former CHS employee in a complaint under the False Claims Act.

In October 2015, Community Health Systems paid $13 million to the United States Department of Justice to resolve allegations related to the False Claims Act.

After CHS agreed in 2015 to sell Memorial Hospital of Salem County in New Jersey to Prime Healthcare Foundation, a nonprofit affiliated with Prime Healthcare Services; the sale was approved by New Jersey in early February 2017.

On December 6, 2016, a former CFO of a CHS hospital was awarded $1.9 million in a whistleblower lawsuit he filed after he was terminated for refusing to submit false financial documents.

In January 2017, a settlement between investors and CHS executives for $60 million was reached. The settlement resolved allegations of "breach of fiduciary duty" by CHS executives.

In March 2017, Quorum's board retained outside counsel in relation to whether Community Health Systems had committed fraud with regards to financial projections for Quorum, and whether any of its current management may have been involved in any possible fraud. In June 2017 Quorum said although the investigation did not produce "conclusive evidence" of fraud the projections appeared to be incompetent at best.

In April–July 2017, Community Health Systems rejected overtures from key Lutheran Health Network doctors to facilitate sale of its profitable network in CHS to a third party, after assertions of continual lack of re-investment into the network's facilities and staff by CHS management. After those discussions/accusations became public, several key leaders of the affiliated hospitals, Lutheran and Dupont, and the network were fired or resigned. Key prominent local community leaders Chuck Surack and Tom Kelley resigned from the Lutheran Health Network's and hospitals' advisory boards.

On March 13, 2018, it was reported that the company had hired financial advisory firm Lazard to help address long-term debt.

On August 1, 2018, CHS completed the sale of 425-bed Munroe Regional Medical Center in Ocala, Fla., to Altamonte Springs, Fla.-based Adventist Health System.

On May 22, 2019, AdventHealth announced they had signed definitive agreements to purchase 193-bed Heart of Florida Regional Medical Center in Davenport, Florida, and 160-bed Lake Wales Medical Center in Lake Wales, Florida, from affiliates of CHS.

In December 2019, CHS announced that subsidiaries of the company have completed the sale of three Virginia hospitals – Southside Regional Medical Center in Petersburg, Southampton Memorial Hospital in Franklin, and Southern Virginia Regional Medical Center in Emporia, effective on January 1, 2020.

On April 27, 2020, CHS announced that an affiliate of the company has signed a definitive agreement to sell its majority ownership interest in 84‑bed St. Cloud Regional Medical Center and its associated healthcare operations in St. Cloud, Florida, to a subsidiary of Orlando Health. Orlando Health currently holds minority ownership interest in St. Cloud and will purchase the remaining interest through this transaction.

On September 30, 2020, CHS announced that an affiliate of the company has completed the sale of 480-bed Bayfront Health St. Petersburg and its associated assets to a subsidiary of Orlando Health.

In its annual Form 10-K filed in 2019, it identified Florida, Texas and Indiana as areas of geographic concentration.

In 2014, CHS had around 200 hospitals, but the number had declined to around 85 in 2021.

From March 2020 to May 2021, during the COVID-19 pandemic, CHS filed more than 19,000 lawsuits against individuals for not being able to pay off their medical debt (some from hospitals it no longer owned) even as the company collected over $700 million in Covid relief funds from the federal government. Many of these lawsuits were against people who could not pay the legal fees to challenge CHS in court. (Due to the fact that these are civil suits and not criminal suits, the defendants do not receive a state-appointed lawyer.) In 2020, CHS posted its most profitable year in at least a decade.

Predatory liens practices

Lawsuits have been filed against CHS hospitals for alleged predatory liens practices where hospitals file for liens rather than bill individuals' health insurers, resulting in massive fees for patients.

出典: Wikipedia (英語), CC BY-SA 4.0 · Wikipediaで表示 ↗

Wikidata ↗

セクターHealth Care 業種Health Care 従業員44,000 国US

10年間のパフォーマンス 収益、純利益、利益率、EPSのトレンド

06
収益$12.48B
2016-12-31 → 2025-12-31
EPS$3.77
2016-12-31 → 2025-12-31
フリーキャッシュフロー$208M
2016-12-31 → 2025-12-31
純利益率2.1%
2018-12-31 → 2025-12-31
バリュエーションと指標 07–12

バリュエーション P/E、P/S、P/B、EV/EBITDA比率 — 株は割高か割安か?

指標 5年トレンド CYH 5年平均 競合中央値 結論
P/E (TTM) 1.55年平均 ≈3.4 ≈3.4 15.5 割安
P/S (TTM) 0.05年平均 ≈0.1 ≈0.1 1.2 割安
株価純資産倍率 (MRQ) -0.35年平均 ≈-0.5 ≈-0.5 · ·
EV / EBITDA (EV/EBITDA) 7.15年平均 ≈13.1 ≈13.1 10.6 割安
株価FCF倍率 (TTM) -2.15年平均 ≈-0.8 ≈-0.8 · ·
株価収益率(P/CF) (TTM) 3.05年平均 ≈-1.6 ≈-1.6 6.5 割安
EV / Revenue (EV/売上高) 0.85年平均 ≈1.0 ≈1.0 · ·
EV / FCF (EV/FCF) 50.55年平均 ≈-4.9 ≈-4.9 · ·

同業他社の中央値は、指標ごとに標準化された基準で計算されており、この銘柄に表示されているTTM/MRQ基準と常に一致するとは限りません。

バリュエーション · ≈ 5年平均 · 業界中央値 · 中央値に対する評価

配当金 利回り、配当性向、配当履歴、5年CAGR

13
権利落ち日金額通貨利回り
12月 13, 2012$0.21USD≈0.84%

決算履歴 EPS実績 vs 予想、サプライズ%、達成率、次回決算日

14
平均サプライズ 37.9%
次回決算 10月 21, 2026
期間レポートEPS ActualEPS 予想サプライズ
2026年6月30日 7月 21, 2026 $-0.19 $-0.06 -201.1%
2026年3月31日 $-0.48 $-0.10 -387.3%
2025年12月31日 $-0.01 $-0.10 90.5%
2025年9月30日 $1.27 $-0.25 610.5%
2025年6月30日 $-0.05 $-0.11 52.6%
2025年3月31日 $-0.03 $-0.08 62.6%

完全なファンダメンタルズ 年次別全指標 — 損益計算書、貸借対照表、キャッシュフロー

15
損益計算書 13
指標 トレンド 2025202420232022202120202019201820172016
Revenue $12.48B$12.63B$12.49B$12.21B$12.37B$11.79B$13.21B$14.15B$15.35B$18.44B
Cost of Revenue $1.86B$1.95B$1.99B$1.98B$2.04B$1.96B$2.15B$2.35B$2.67B$3.01B
Operating Expenses $11.00B$12.09B$11.53B$11.39B$10.97B$10.66B$12.56B$13.95B$17.23B$19.30B
Operating Income $1.49B$542M$957M$821M$1.40B$1.13B$650M$208M$-1.88B$-860M
Interest Income $2M$3M$2M$2M$3M$3M$3M$7M$11M$14M
Pretax Income $724M$-283M$207M$349M$499M$422M$-430M$-715M$-2.83B$-1.72B
Income Tax $48M$79M$191M$170M$131M$-185M$160M$-11M$-449M$-104M
Net Income $509M$-516M$-133M$46M$230M$511M$-675M$-788M$-2.46B$-1.72B
EPS (Basic) $3.81$-3.90$-1.02$0.35$1.82$4.43$-5.93$-6.99$-22.00$-15.54
EPS (Diluted) $3.77$-3.90$-1.02$0.35$1.76$4.39$-5.93$-6.99$-22.00$-15.54
Shares (Basic) 133,564,227132,101,768130,445,677128,808,387126,754,852115,491,022113,739,046112,728,274111,769,821110,730,971
Shares (Diluted) 135,012,240132,101,768130,445,677130,060,319130,597,410116,544,561113,739,046112,728,274111,769,821110,730,971
EBITDA $1.49B$542M$957M$821M$1.40B$1.13B$1.26B$908M$-1.02B$240M
貸借対照表 26
指標 トレンド 2025202420232022202120202019201820172016
Cash & Equivalents $260M$37M$38M$118M$507M$1.68B$216M$196M$563M$238M
Receivables $2.08B$2.29B$2.23B$2.04B$2.06B$1.93B$2.26B$2.35B$2.38B$3.18B
Other Current Assets $381M$358M$275M$235M$269M$338M$358M$400M$462M$568M
Current Assets $3.23B$3.30B$3.21B$3.08B$3.48B$4.51B$3.43B$3.55B$4.07B$4.67B
PP&E (Net) $4.50B$4.78B$5.21B$5.37B$5.55B$5.32B$5.61B$6.14B$7.05B$8.15B
PP&E (Gross) $8.91B$9.16B$9.51B$9.64B$9.76B$9.35B$9.65B$10.30B$11.50B$12.42B
Accum. Depreciation $4.41B$4.38B$4.30B$4.27B$4.20B$4.03B$4.04B$4.16B$4.45B$4.27B
Goodwill $3.32B$3.79B$3.96B$4.17B$4.22B$4.22B$4.33B$4.56B$4.72B$6.52B
Intangibles $7M$15M$20M$2M····$10M$14M
Other Non-current Assets $2.10B$2.17B$2.05B$2.01B$1.91B$1.90B$2.21B$1.54B$1.54B$2.59B
Total Assets $13.20B$14.05B$14.46B$14.67B$15.22B$16.01B$15.61B$15.86B$17.45B$21.94B
Accounts Payable $842M$913M$912M$773M$830M$783M$811M$887M$967M$995M
Accrued Liabilities ······$1.13B$1.09B$1.13B$1.23B
Current Liabilities $2.21B$2.35B$2.14B$2.19B$2.36B$2.81B$2.28B$2.39B$2.36B$2.89B
Capital Leases $537M$535M$563M$605M$535M$524M$487M$84M$287M$302M
Deferred Tax $25M$231M$369M$354M$192M$29M$200M$26M$19M$411M
Other Non-current Liabilities $891M$828M$739M$644M$827M$1.60B$894M$1.01B$1.36B$1.57B
Total Liabilities $14.04B$15.37B$15.28B$15.40B$16.03B$17.06B$17.25B$16.82B$17.61B$19.66B
Long-term Debt $10.40B$11.45B$11.49B$11.63B$12.14B$12.22B$13.40B$13.60B$13.91B$15.24B
Total Debt $10.38B$11.43B$11.47B$11.61B$12.11B$12.09B$13.38B···
Common Stock $1M$1M$1M$1M$1M$1M$1M$1M$1M$1M
Retained Earnings $-3.57B$-4.08B$-3.56B$-3.43B$-3.48B$-3.71B$-4.22B$-3.54B$-2.76B$-299M
AOCI $-9M$-10M$-14M$-21M$-14M$-13M$-9M$-10M$-21M$-62M
Stockholders' Equity $-1.39B$-1.91B$-1.39B$-1.37B$-1.37B$-1.62B$-2.22B$-1.53B$-767M$1.61B
Liabilities + Equity $13.20B$14.05B$14.46B$14.67B$15.22B$16.01B$15.61B$15.86B$17.45B$21.94B
Shares Outstanding 138,626,917138,919,641136,774,911134,703,717132,146,282129,612,117117,822,631116,248,376114,651,004113,876,580
キャッシュフロー 13
指標 トレンド 2025202420232022202120202019201820172016
D&A $426M$486M$505M$534M$540M$558M$608M$700M$861M$1.10B
Stock-based Comp $11M$17M$22M$20M$25M$13M$10M$13M$24M$46M
Deferred Tax $-243M$-116M$35M$165M$171M$-187M$203M$-3M$-454M$-116M
Restructuring ····$3M·····
Other Non-cash ······$239M$352M$2.80B$1.83B
Operating Cash Flow $543M$480M$210M$300M$-131M$2.18B$385M$274M$773M$1.14B
CapEx $335M$360M$467M$415M$469M$440M$438M$527M$564M$744M
Investing Cash Flow $847M$-275M$-26M$-259M$-524M$177M$-2M$-245M$1.07B$630M
Net Debt Issued $-6.52B$-5.06B$-4.32B$-2.36B$-4.43B$-5.49B$-3.56B$-2.03B$-5.39B$-6.71B
Financing Cash Flow $-1.17B$-206M$-264M$-430M$-514M$-895M$-363M$-396M$-1.52B$-1.71B
Net Change in Cash $223M$-1M$-80M$-389M$-1.17B$1.46B$20M$-367M$325M$54M
Taxes Paid $249M$171M$91M$-6M$-4M$-2M$3M$19M$-4M$16M
Free Cash Flow $208M$120M$-257M$-115M$-600M$1.74B$-53M$-253M$209M$393M
収益性 7
指標 トレンド 2025202420232022202120202019201820172016
Operating Margin 11.9%4.3%7.7%6.7%11.3%9.6%4.9%1.5%··
Net Margin 4.1%-4.1%-1.1%0.38%1.9%4.3%-5.1%-5.6%··
Pretax Margin 5.8%-2.2%1.7%2.9%4.0%3.6%-3.3%-5.1%··
EBITDA Margin 11.9%4.3%7.7%6.7%11.3%9.6%9.5%6.4%··
ROA 3.7%-3.6%-0.91%0.31%1.5%3.2%-4.3%-4.7%-12.5%-7.1%
ROE -30.8%31.2%9.6%-3.4%-15.3%-26.6%36.0%68.5%-580.0%-61.1%
ROIC 15.5%7.3%0.73%4.1%9.6%15.5%8.0%-13.3%206.0%-50.0%
流動性と支払能力 4
指標 トレンド 2025202420232022202120202019201820172016
Current Ratio 1.51.41.51.41.51.61.51.51.71.6
Quick Ratio 1.11.01.11.01.11.31.11.11.31.2
Debt / Equity -7.4-6.0-8.2-8.5-8.8-7.4-6.0···
LT Debt / Equity -7.4-6.0-8.2-8.5-8.8-7.4-6.0···
効率性 2
指標 トレンド 2025202420232022202120202019201820172016
Asset Turnover 0.90.90.90.80.80.70.80.8··
Receivables Turnover 5.75.65.86.06.25.65.76.0··
1株あたり 5
指標 トレンド 2025202420232022202120202019201820172016
Book Value / Share $-10.06$-13.78$-10.18$-10.15$-10.38$-12.54$-18.82$-13.20$-6.69$14.18
Revenue / Share $92.47$95.64$95.75$93.89$94.70$101.15$116.14$125.57··
Cash Flow / Share $4.02$3.63$1.61$2.31$-1.00$18.69$3.38$2.43$6.92$10.27
Cash / Share $1.88$0.27$0.28$0.88$3.84$12.93$1.83$1.69$4.91$2.09
EPS (TTM) $3.77$-3.90$-1.02$0.35$1.76$4.39$-5.93$-6.99$-22.00$-15.54
成長率 9
指標 トレンド 2025202420232022202120202019201820172016
Revenue YoY -1.2%1.1%2.3%-1.3%4.9%·····
Revenue CAGR 3Y 0.74%0.71%1.9%·······
Revenue CAGR 5Y 1.1%·········
EPS YoY ···-80.1%-59.9%·····
EPS CAGR 3Y 120.8%·········
EPS CAGR 5Y -3.0%·········
Net Income YoY ···-80.0%-55.0%·····
Net Income CAGR 3Y 122.8%·········
Net Income CAGR 5Y -0.08%·········
バリュエーション(TTM) 13
指標 トレンド 2025202420232022202120202019201820172016
Revenue TTM $12.48B$12.63B$12.49B$12.21B$12.37B$11.79B$13.21B$14.15B$15.35B$18.44B
Net Income TTM $509M$-516M$-133M$46M$230M$511M$-675M$-788M$-2.46B$-1.72B
Market Cap $433M$415M$428M$582M$1.76B$963M$342M$328M$488M$637M
Enterprise Value $10.55B$11.81B$11.86B$12.08B$13.36B$11.38B$13.51B···
P/E 0.8-0.8-3.112.37.61.7-0.5-0.4-0.2-0.4
P/S 0.00.00.00.00.10.10.00.00.00.0
P/B -0.3-0.2-0.3-0.4-1.3-0.6-0.2-0.2-0.60.4
P / Cash Flow 0.80.92.01.9-13.40.40.91.20.60.6
P / FCF 2.13.5-1.7-5.1-2.90.6-6.4-1.32.31.6
EV / EBITDA 7.121.812.414.79.510.110.7···
EV / FCF 50.798.4-46.1-105.0-22.36.5-254.9···
EV / Revenue 0.80.90.91.01.11.01.0···
Earnings Yield 120.8%-130.4%-32.6%8.1%13.2%59.1%-204.5%-247.9%-516.4%-278.0%

最新期間は左側 · null値は・として表示

財務諸表 損益計算書、貸借対照表、キャッシュフロー — 年次、過去5年間

16
指標 2025-12-312024-12-312023-12-312022-12-312021-12-31
収益 $12.48B $12.63B $12.49B $12.21B $12.37B
営業利益率 % 11.9% 4.3% 7.7% 6.7% 11.3%
純利益 $509M $-516M $-133M $46M $230M
希薄化後EPS $3.77 $-3.90 $-1.02 $0.35 $1.76

機関投資家(13F) 196 提出者 · $415.1M合計 · 時点 2026年9月30日

17

四半期SECフォーム13Fでこの株式の保有を報告している機関。ロングポジションのみ。単一の提出者は、別々のオプションレッグで2回表示される場合があります。 大きな反対売買のプット/コール・レッグは、通常、マーケットメイクまたはヘッジされた在庫を反映しており、方向性への確信を示すものではありません。

保有者 196
保有価値 $415.1M
新規ポジション 31
解消済みポジション 24
機関投資家の動向 — Q2 2026 対 前四半期
新規ポジション 解消済みポジション 増加 減少 純株式数増減
31 (+9 前期比) 24 (+4 前期比) 69 (+6 前期比) 54 (-9 前期比) +7.0M

Q1 2026と比較しました。 SECフォーム13Fの提出期限は四半期末から45日後ですが、遅延提出者向けの短いバッファーが含まれます。この期間内の四半期は、直近で完全に報告されたペアを優先するためスキップされます。

機関投資家 評価額 株式数 % 追跡された13Fのうち タイプ
CastleKnight Management LP $44,704,517 13,384,586 10.77% 株式数
Apollo Management Holdings, L.P. $39,610,817 11,859,526 9.54% 株式数
BlackRock, Inc. $36,507,995 10,930,538 8.79% 株式数
VANGUARD GROUP INC $28,605,579 9,168,455 6.89% 株式数
Eversept Partners, LP $26,267,680 7,864,575 6.33% 株式数
NOMURA HOLDINGS INC $22,388,384 6,703,109 5.39% 株式数
VANGUARD CAPITAL MANAGEMENT LLC $17,668,370 5,289,931 4.26% 株式数
WHITEBOX ADVISORS LLC $12,467,362 3,732,743 3.00% 株式数
GEODE CAPITAL MANAGEMENT, LLC $10,582,352 3,167,702 2.55% 株式数
STATE STREET CORP $10,226,622 3,061,863 2.46% 株式数
VANGUARD PORTFOLIO MANAGEMENT LLC $10,082,117 3,018,598 2.43% 株式数
Saba Capital Management, L.P. $9,626,444 2,882,169 2.32% 株式数
Owl Creek Asset Management, L.P. $8,452,277 2,530,622 2.04% 株式数
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $8,176,380 2,448,018 1.97% 株式数
DIMENSIONAL FUND ADVISORS LP $7,854,253 2,351,460 1.89% 株式数
D. E. Shaw & Co., Inc. $7,829,388 2,344,128 1.89% 株式数
AQR CAPITAL MANAGEMENT LLC $7,651,362 2,290,827 1.84% 株式数
TWO SIGMA INVESTMENTS, LP $7,365,822 2,205,336 1.77% 株式数
Diameter Capital Partners LP $6,138,793 1,837,962 1.48% 株式数
BANK OF AMERICA CORP /DE/ $5,903,847 1,767,619 1.42% 株式数
GOLDMAN SACHS GROUP INC $5,868,073 1,756,908 1.41% 株式数
TWO SIGMA ADVISERS, LP $5,816,476 1,864,255 1.40% 株式数
CARRONADE CAPITAL MANAGEMENT, LP $5,230,000 1,565,847 1.26% 株式数
Allianz Asset Management GmbH $5,167,919 1,547,281 1.24% 株式数
MORGAN STANLEY $4,800,489 1,437,272 1.16% 株式数
NORTHERN TRUST CORP $4,681,414 1,401,621 1.13% 株式数
Silver Rock Financial LP $3,674,000 1,100,000 0.89% 株式数
CITADEL ADVISORS LLC $3,475,360 1,040,527 0.84% 株式数
Assenagon Asset Management S.A. $2,788,275 834,813 0.67% 株式数
VANGUARD FIDUCIARY TRUST CO $2,642,231 791,087 0.64% 株式数
Jefferies Financial Group Inc. $2,481,286 742,900 0.60% 株式数
Alta Fundamental Advisers LLC $2,161,411 647,129 0.52% 株式数
Bank of New York Mellon Corp $2,122,084 635,354 0.51% 株式数
MARSHALL WACE, LLP $1,906,575 570,831 0.46% 株式数
MILLENNIUM MANAGEMENT LLC $1,701,580 509,455 0.41% 株式数
ExodusPoint Capital Management, LP $1,664,603 498,384 0.40% 株式数
READYSTATE ASSET MANAGEMENT LP $1,657,729 496,326 0.40% 株式数
WOLVERINE ASSET MANAGEMENT LLC $1,339,674 401,100 0.32% コールオプション
Helix Partners Management LP $1,336,000 400,000 0.32% 株式数
Susquehanna Portfolio Strategies, LLC $1,280,940 383,515 0.31% 株式数
Voleon Capital Management LP $1,247,032 373,363 0.30% 株式数
Invesco Ltd. $1,076,599 322,335 0.26% 株式数
TUDOR INVESTMENT CORP ET AL $999,388 299,218 0.24% 株式数
Pathstone Holdings, LLC $895,621 268,150 0.22% 株式数
Prescott Group Capital Management, L.L.C. $863,076 258,406 0.21% 株式数
UBS Group AG $851,089 254,817 0.21% 株式数
MILLENNIUM MANAGEMENT LLC $835,000 250,000 0.20% プットオプション
FEDERATED HERMES, INC. $812,599 243,293 0.20% 株式数
LPL Financial LLC $737,239 220,730 0.18% 株式数
IEQ CAPITAL, LLC $657,963 196,995 0.16% 株式数

196件の機関投資家をすべて表示 →

アクティビストおよび5%超のオーナー 1保有

18

SECスケジュール13Dを提出した投資家 — 発行体の影響を与える意図(アクティビストの保有、取締役会キャンペーン、M&A)を持つ5%超の受益権所有。各行は、その提出者のポジションの最新の既知の状態を示します。

提出者 提出済み 保有 ステータス 目的 提出書類
Tianqiao Chen, Shanda Media Limited, Shanda Global Investment Limited, Shanda Global Capital Limited, Shanda Asset Management Holdings Limited ×10 提出書類 2021年3月11日 · 初回提出 · SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

企業インサイダー 56 人のインサイダー · 29人の役員 · 23人の取締役

19
インサイダー 役職 最終アクティビティ 保有株式数 12ヶ月購入 12ヶ月売却 12ヶ月純額
Kevin J Hammons CEO 2026年3月1日 A 895,545 0 0 $0
Tim Hingtgen CEO 2025年3月1日 A 1,388,781 0 0 $0
Jason K Johnson EVP & CFO 2026年3月1日 A 268,439 0 0 $0
Thomas J Aaron EVP and CFO 2019年12月7日 F 241,515 0 0 $0
Larry W Cash President and CFO 2017年3月1日 A 568,152 0 0 $0
Miguel S Benet President and CMO 2025年3月1日 D 47,635 0 0 $0
Austen D Mason Regional President 2025年3月1日 A 142,500 0 0 $0
Mark B Medley Regional President 2025年3月1日 A 128,637 0 0 $0
Chad A Campbell Regional President 2025年3月1日 A 136,815 0 0 $0
Charles J Cova Regional President 2024年3月1日 A 58,701 0 0 $0
Lynn T Simon President and CMO 2024年3月1日 A 482,657 0 0 $0
Beryl Ramsey Division President 2019年3月1日 A 62,969 0 0 $0
Patton Paul Smith Division President 2019年3月1日 F 119,017 0 0 $0
Iii John W Mcclellan Division President 2017年3月1日 A 41,242 0 0 $0
Robert O Horrar Division President 2017年3月1日 A 68,649 0 0 $0
Martin Bonick Division President 2017年3月1日 A 100,458 0 0 $0
Michael T Portacci Division President 2017年3月1日 A 110,156 0 0 $0
Thomas Daniel Miller Division President 2016年3月1日 A 112,107 0 0 $0
David Lewis Miller President and COO 2016年3月1日 A 440,840 0 0 $0
William S Hussey Division President 2015年10月28日 M 121,568 0 0 $0
Martin Dewayne Smith Division President 2015年6月3日 M 94,111 0 0 $0
Gary D Newsome Division President - Group Ops 2008年8月25日 M 118,286 0 0 $0
David V. Rice EVP-Clinical Operations & CMO 2026年6月1日 A 30,000 0 0 $0
Phillip A. Posey SVP & CAO 2026年3月1日 A 51,736 0 0 $0
Justin D Pitt Pres,Chief Legal&Admin Officer 2026年3月1日 A 287,750 0 0 $0
Kevin A Stockton EVP, Operations & Development 2026年3月1日 A 208,290 0 0 $0
Rachel A Seifert Executive VP and Secretary 2017年3月1日 F 243,065 0 0 $0
Mark T Buford SVP/Chief Accounting Officer 2012年2月25日 F 78,379 0 0 $0
Martin G Schweinhart Senior Vice President 2006年3月1日 A 40,354 0 0 $0
William Norris Jennings 取締役 2026年8月25日 S 38,468 0 1 $-118,400
Ranga K Krishnan 取締役 2026年6月30日 M 170,023 0 0 $0
Fawn D Lopez 取締役 2026年3月1日 A · 0 0 $0
Ronald L Burgess JR 取締役 2026年3月1日 A · 0 0 $0
Susan W Brooks 取締役 2026年3月1日 A 108,695 0 0 $0
Hubert James Williams 取締役 2026年3月1日 A 211,863 0 0 $0
Joseph Arthur Hastings 取締役 2026年3月1日 A 0 0 0 $0
Elizabeth T Hirsch 取締役 2026年3月1日 A 162,059 0 0 $0
James S. Ely III 取締役 2026年3月1日 A 412,876 0 0 $0
John A Fry 取締役 2026年3月1日 A 268,966 0 0 $0
John A Clerico 取締役 2026年3月1日 A 368,763 0 0 $0
Michael Dinkins 取締役 2026年3月1日 A 225,882 0 0 $0
Wayne T Smith 取締役 2026年3月1日 A 5,217,579 0 0 $0
Julia B North 取締役 2021年3月1日 A 162,056 0 0 $0
Mitchell H Watson JR 取締役 2017年5月16日 M 22,594 0 0 $0
Harvey Klein MD 取締役 2010年3月15日 M 10,383 0 0 $0
Dale F Frey 取締役 2008年3月31日 A 20,000 0 0 $0
Thomas H Lister 取締役 2004年9月21日 S 0 0 0 $0
Thodore Forstmann 取締役 2004年9月21日 S 0 0 0 $0
Sandra Horbach 取締役 2004年9月21日 S 0 0 0 $0
Robert J Dole 取締役 2004年5月6日 S 0 0 0 $0
FLC XXIX PARTNERSHIP LP 10%オーナー 2004年9月21日 S 0 0 0 $0
FLC XXX PARTNERSHIP LP 10%オーナー 2004年9月21日 S 0 0 0 $0
Winston Hutchins 10%オーナー 2004年9月21日 S 0 0 0 $0
FORSTMANN LITTLE & CO SUB DEBT & EQU MGMT BUYOUT PART VI LP 10%オーナー 2004年9月21日 S 0 0 0 $0
FORSTMANN LITTLE & CO EQUITY PARTNERSHIP V L P 10%オーナー 2004年9月21日 S 0 0 0 $0
Benjamin C Fordham · 2021年3月1日 A 254,608 0 0 $0

SECフォーム3/4/5提出書類からのインサイダー;純額=公開市場のP/Sのみ

ETF保有状況 25のETFが保有

20

ウェイトは直接株式保有(N-PORT)のみを反映しています。レバレッジ型またはデリバティブベースのファンドは、表示されていない追加のスワップエクスポージャーを保有している可能性があります。

ファンド ウェイト 単位 時点 ソース
BSJR · Invesco Exchange-Traded Self-Indexe… 2.68% 23,297,000 2026年10月1日 日次
EBIT · Harbor ETF Trust 0.45% 19,210 NS 2026年7月31日 N-PORT
IWC · iShares Trust 0.09% 443,690 SH 2026年9月11日 日次
IHF · iShares Trust 0.05% 223,947 SH 2026年9月11日 日次
VTWV · VANGUARD SCOTTSDALE FUNDS 0.03% 113,109 SH 2026年8月19日 日次
NEAR · iShares U.S. ETF Trust 0.03% 1,340,000 SH 2026年9月11日 日次
PRFZ · Invesco Exchange-Traded Fund Trust 0.02% 226,491 SH 2026年10月1日 日次
IWM · iShares Trust 0.01% 3,425,206 SH 2026年9月11日 日次
RSSL · Global X Funds 0.01% 62,038 NS 2026年7月31日 N-PORT
VTWO · VANGUARD SCOTTSDALE FUNDS 0.01% 746,733 SH 2026年8月19日 日次
VHT · VANGUARD WORLD FUND 0.01% 349,881 SH 2026年8月19日 日次
DFAS · Dimensional ETF Trust 0.01% 289,348 NS 2026年7月31日 N-PORT
DFAC · Dimensional ETF Trust 0.00% 202,789 NS 2026年7月31日 N-PORT
DFAU · Dimensional ETF Trust 0.00% 33,838 NS 2026年7月31日 N-PORT
ITOT · iShares Trust 0.00% 203,848 SH 2026年9月11日 日次
IWV · iShares Trust 0.00% 42,177 SH 2026年9月3日 日次
DCOR · Dimensional ETF Trust 0.00% 6,184 NS 2026年7月31日 N-PORT
DFUS · Dimensional ETF Trust 0.00% 31,135 NS 2026年7月31日 N-PORT
VXF · VANGUARD INDEX FUNDS 0.00% 1,347,195 SH 2026年8月19日 日次
VTI · VANGUARD INDEX FUNDS 0.00% 3,813,888 SH 2026年8月19日 日次
VTHR · VANGUARD SCOTTSDALE FUNDS 0.00% 9,817 SH 2026年8月19日 日次
DFSU · Dimensional ETF Trust 0.00% 24 NS 2026年7月31日 N-PORT
VGHY · VANGUARD FIXED INCOME SECURITIES FU… · · 2026年7月15日 日次
VPLS · VANGUARD MALVERN FUNDS · · 2026年7月15日 日次
IWN · iShares Trust · 1,223,127 SH 2026年9月11日 日次

CYH アナリストコンセンサス 強気・弱気のアナリストの見解、12ヶ月の目標株価、アップサイド

21
レーティング · 16 アナリスト 保有
中央値ターゲット $3.12 +14.9%
1 6.2% 強い買い
1 6.2% 買い
6 37.5% 保有
7 43.8% 売り
1 6.2% 強い売り

12ヶ月目標株価

8 アナリスト · 2026-10-01

平均値ターゲット $3.16 +16.0%

現在 現在価格 $2.72
安値$2.00 平均値$3.16 高値$4.00

同業他社比較(GICSサブインダストリー) 主要メトリクスとセクターピアの比較

22

FY基準、価格は各社の直近年度末終値。

ティッカー 時価総額 P/E 売上高 YoY 純利益率 ROE 粗利益率
CYH $433M 0.8 -1.2% 4.1% -30.8% ·
SGRY $2.00B -25.3 6.2% -2.4% -4.5% ·
NUTX $1.17B 15.7 82.4% 8.1% 30.6% 50.8%
ARDT $1.26B 9.2 6.0% 2.1% 11.2% ·
USPH · 55.0 16.3% 5.1% 8.2% 19.2%
STLN · · · · · ·
JYNT $123M 45.9 5.2% 5.3% 16.3% ·
HCA $104.86B 16.5 7.1% 9.0% -159.1% ·

最新ニュース この会社に言及した最近の見出し

23

マイ指標 あなた専用のウォッチリスト — 決算詳細から選択した行

26

重視する指標を選択してください — 上記の「財務諸表」の任意の行の横にある「+」をクリックしてください。

選択内容は保存され、すべてのティッカーで引き継がれます。

出典:SEC 10-Q 提出日 7月 23, 2026